Vertex Pharmaceuticals (VRTX) Net Income Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 30.42 Bn | 30.42 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.57% |
| Dec 31, 2025 | 14.54% |
| Sep 30, 2025 | 10.16% |
| Jun 30, 2025 | 4.29% |
| Mar 31, 2025 | 1.40% |
| Dec 31, 2024 | 9.38% |
| Sep 30, 2024 | 78.61% |
| Jun 30, 2024 | -72.87% |
| Mar 31, 2024 | 32.56% |
| Dec 31, 2023 | -8.68% |
| Sep 30, 2023 | 51.80% |
| Jun 30, 2023 | 34.73% |
| Mar 31, 2023 | 25.22% |
| Dec 31, 2022 | 51.62% |
| Sep 30, 2022 | 39.05% |
| Jun 30, 2022 | 91.87% |
| Mar 31, 2022 | 25.02% |
| Dec 31, 2021 | 94.37% |
| Sep 30, 2021 | 88.10% |
| Jun 30, 2021 | 30.97% |
| Mar 31, 2021 | 82.22% |
| Dec 31, 2019 | 388.88% |
| Sep 30, 2019 | 289.87% |
| Jun 30, 2019 | 291.07% |
| Mar 31, 2019 | 278.65% |
| Dec 31, 2018 | 62.47% |
| Sep 30, 2018 | 81.73% |
| Jun 30, 2018 | 137.33% |
| Mar 31, 2018 | 110.84% |
| Dec 31, 2017 | 27.04% |
| Sep 30, 2017 | -61.52% |
| Jun 30, 2017 | 23.77% |
| Mar 31, 2017 | 23.21% |
| Dec 31, 2016 | -31.80% |
| Sep 30, 2016 | -16.79% |